457 related articles for article (PubMed ID: 25957621)
1. The Cholangiopathies.
Lazaridis KN; LaRusso NF
Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
[TBL] [Abstract][Full Text] [Related]
2. Biology of Cholangiocytes: From Bench to Bedside.
Yoo KS; Lim WT; Choi HS
Gut Liver; 2016 Sep; 10(5):687-98. PubMed ID: 27563020
[TBL] [Abstract][Full Text] [Related]
3. [Physiologic and pathologic experimental models for studying cholangiocytes].
Lee SO
Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory and neoplastic cholangiopathies.].
Alvaro D; Bragazzi MC; Ridola L
Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
[TBL] [Abstract][Full Text] [Related]
6. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
7. The intrahepatic cholangiopathies.
Birnbaum A; Suchy FJ
Semin Liver Dis; 1998; 18(3):263-9. PubMed ID: 9773426
[TBL] [Abstract][Full Text] [Related]
8. The dynamic biliary epithelia: molecules, pathways, and disease.
O'Hara SP; Tabibian JH; Splinter PL; LaRusso NF
J Hepatol; 2013 Mar; 58(3):575-82. PubMed ID: 23085249
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.
Esparza-Baquer A; Labiano I; Bujanda L; Perugorria MJ; Banales JM
Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):15-27. PubMed ID: 26774196
[TBL] [Abstract][Full Text] [Related]
10. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
Pollheimer MJ; Fickert P; Stieger B
Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and benign biliary tract diseases.
Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
[TBL] [Abstract][Full Text] [Related]
12. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
13. The pathobiology of biliary epithelia.
Alpini G; McGill JM; Larusso NF
Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
15. Destructive intrahepatic bile duct diseases.
Desmet VJ
Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
[TBL] [Abstract][Full Text] [Related]
16. Cholangiopathies - Towards a molecular understanding.
Tam PKH; Yiu RS; Lendahl U; Andersson ER
EBioMedicine; 2018 Sep; 35():381-393. PubMed ID: 30236451
[TBL] [Abstract][Full Text] [Related]
17. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the intrahepatic biliary epithelium.
Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
[TBL] [Abstract][Full Text] [Related]
19. Review: Pathogenesis of cholestatic liver diseases.
Yokoda RT; Rodriguez EA
World J Hepatol; 2020 Aug; 12(8):423-435. PubMed ID: 32952871
[TBL] [Abstract][Full Text] [Related]
20. Bile Acids and Biliary Fibrosis.
Aseem SO; Hylemon PB; Zhou H
Cells; 2023 Mar; 12(5):. PubMed ID: 36899928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]